Most Read Articles
6 days ago
The consumption of red and processed meats does not seem to affect the likelihood of symptom relapse among Crohn’s disease (CD) patients in relapse, reports a recent study.
Pearl Toh, 4 days ago
In addition to the known evils of maternal smoking during pregnancy on the son’s semen quality, prenatal exposure to paternal smoking can also be harmful, according to data from a large Danish National Birth Cohort (DNBC) presented at the ESHRE 2019 Meeting.
6 days ago
Treatment with metformin may improve whole-body and peripheral insulin resistance (IR) in youth who are overweight/obese with type 1 diabetes (T1D), according to a study.
4 days ago
Fluticasone, swallowed from a multidose inhaler, and oral viscous budesonide slurry have comparable efficacies as initial treatment for eosinophilic oesophagitis, a recent study has found.

Aspirin may avert glioma

18 Mar 2019

Aspirin use is associated with a lower risk of glioma, according to data from the Glioma International Case-Control Study (GICC).

GICC involved 4,533 glioma patients and 4,171 healthy controls who were then interviewed regarding their use of aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs). Regular use was defined as use at least once per week for ≥6 months. Researchers applied restricted maximum likelihood meta-regression models to aggregate site-specific estimates and to combine GICC estimates with previously published studies.

A total of 1,641 participants were regular aspirin users: 764 (19.0 percent) glioma patients and 877 (22.7 percent) controls. Major indications included headaches, muscle/joint aches and cardioprevention. On the other hand, 542 (13.9 percent) patients and 533 (14.6 percent) controls reported regular NSAID use.

A history of daily aspirin use for ≥6 months was associated with a 38-percent decrease in the risk of glioma compared with nonuse (adjusted meta-odds ratio [mOR], 0.62; 95 percent CI, 0.54–0.70). Moreover, a significant duration-response trend was observed (p=1.67×10−17), with lower ORs for increasing duration of aspirin use. This trend was not seen for NSAID use.

In the meta-analysis pooling GICC data with five previous studies, a marginally significant association between use of aspirin and glioma emerged (mOR, 0.84; 0.70–1.02) but none for NSAID use.

Researchers noted that the reduced glioma risk associated with regular aspirin use is consistent with reports from previous studies, and that the duration-response trend observed provides a strong rationale for further investigation. [Eur J Epidemiol 2016;31:917-925; Int J Cancer 2012;131:E1031-E1037]

Further studies that utilize more comprehensive exposure assessment strategies and investigate each NSAID separately in order to account for differences in COX-2 selectivity or pharmacological properties are needed.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
The consumption of red and processed meats does not seem to affect the likelihood of symptom relapse among Crohn’s disease (CD) patients in relapse, reports a recent study.
Pearl Toh, 4 days ago
In addition to the known evils of maternal smoking during pregnancy on the son’s semen quality, prenatal exposure to paternal smoking can also be harmful, according to data from a large Danish National Birth Cohort (DNBC) presented at the ESHRE 2019 Meeting.
6 days ago
Treatment with metformin may improve whole-body and peripheral insulin resistance (IR) in youth who are overweight/obese with type 1 diabetes (T1D), according to a study.
4 days ago
Fluticasone, swallowed from a multidose inhaler, and oral viscous budesonide slurry have comparable efficacies as initial treatment for eosinophilic oesophagitis, a recent study has found.